<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2026-01-25</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2026-01-25</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>22</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
æ–°å‹Pyrrolidine-chalconeè¡ç”Ÿç‰©é€šè¿‡åŒé¶å‘MDM2-p53è½´å’Œé“æ­»äº¡é€šè·¯ï¼Œå±•ç°ååŒæŠ—å®«é¢ˆç™Œæ´»æ€§ï¼›CRISPRæ¿€æ´»ç­›é€‰é¦–æ¬¡å®ç°ä½“å†…è‚¿ç˜¤å¾®ç¯å¢ƒè°ƒæ§åŸºå› çš„ç†æ€§è®¾è®¡ï¼Œä¸ºå…ç–«åŸºå› æ²»ç–—æä¾›æ–°ç­–ç•¥ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚ é“èŒç¾¤ä¸ç‚ç—‡æ€§è‚ ç—…ï¼ˆIBDï¼‰å…ç–«ååº”çš„å•ç»†èƒRNAæµ‹åºç ”ç©¶ã€‚<br />
- è‚¿ç˜¤å¾®ç¯å¢ƒã€ä»£è°¢é‡ç¼–ç¨‹ï¼ˆå¦‚è‘¡è„ç³–ã€è°·æ°¨é…°èƒºä¾èµ–æ€§ä»£è°¢ï¼‰ä¸ç™Œç—‡æ²»ç–—ï¼ˆå¦‚PD-L1æŠ‘åˆ¶å‰‚ã€å…ç–«åŸºå› ç–—æ³•ï¼‰çš„æœºåˆ¶æ¢ç´¢ã€‚<br />
- ç¥ç»ç‚ç—‡æ€§ç–¾ç—…ï¼ˆå¦‚Rasmussenè„‘ç‚ï¼‰çš„å…ç–«å›¾è°±è§£æã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å•ç»†èƒRNAæµ‹åºï¼ˆscRNA-seqï¼‰åœ¨è§£æå¤æ‚ç”Ÿç‰©å­¦è¿‡ç¨‹ï¼ˆå¦‚å…ç–«ååº”ã€å‘è‚²ã€ç–¾ç—…ï¼‰ä¸­çš„å¹¿æ³›åº”ç”¨ã€‚<br />
- CRISPRæ¿€æ´»ï¼ˆCRISPRaï¼‰åœ¨ä½“å†…è‚¿ç˜¤å¾®ç¯å¢ƒè°ƒæ§ç ”ç©¶ä¸­çš„åˆ›æ–°åº”ç”¨ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
åŒ–ç–—é€šè¿‡é‡å¡‘è‚ é“èŒç¾¤æœ‰æ•ˆæŠ‘åˆ¶ç™Œç—‡è½¬ç§»ï¼›ä¸€é¡¹åŸºå› ç ”ç©¶è¡¨æ˜ï¼ŒAPOEåŸºå› å¯èƒ½è§£é‡Šç»å¤§å¤šæ•°é˜¿å°”èŒ¨æµ·é»˜ç—…ç—…ä¾‹ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚ é“å¾®ç”Ÿç‰©ä¸ç™Œç—‡è½¬ç§»çš„è°ƒæ§æœºåˆ¶<br />
- é•¿è¯»é•¿RNAæµ‹åºæŠ€æœ¯åœ¨åŸºå› ç»„å­¦ç ”ç©¶ä¸­çš„åº”ç”¨<br />
- é˜¿å°”èŒ¨æµ·é»˜ç—…é—ä¼ å­¦ç—…å› æ¢ç©¶<br />
- æ–°å‹å‚¬åŒ–å‰‚åœ¨å¡‘æ–™å›æ”¶é¢†åŸŸçš„åº”ç”¨</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- åˆ©ç”¨åŒ–ç–—è¯±å¯¼çš„è‚ é“èŒç¾¤æ”¹å˜å®ç°æŠ—è½¬ç§»<br />
- åŸºäºé•¿è¯»é•¿RNAæµ‹åºæŠ€æœ¯å¤§å¹…æ‰©å±•lncRNAç›®å½•<br />
- å‘ç°é’¨ç¢³åŒ–ç‰©æ–°å‹å‚¬åŒ–å‰‚ï¼Œæ˜¾è‘—æå‡å¡‘æ–™ upcycling æ•ˆç‡</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (18æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE316876 ç‚ç—‡æ€§è‚ ç—…æœŸé—´è‚ é“èŒç¾¤è§¦å‘çš„å…ç–«ååº”çš„å•ç»†èƒRNAæµ‹åºåˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€RNA-seqã€single-cellã€gutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zichan He ; Xueying Li ; Huabin Liang ; Baofa Sun ; Lingyi ChenSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusWhether gut microbiota is pro-inflammation or anti-inflammation during the development of inflammatory bowel disease (IBD) remains controversial. To clarify this issue, using a dextran sodium sulfate (DSS) induced IBD mouse model, we showed that compared to specific pathogen free (SPF) mice, pseudo germ-free (pGF) mice exhibit milder IBD symptoms, suggesting a pro-inflammatory role of gut microbiota. We then employed single-cell RNA-sequencing to profile the immune cells in the colon of SPF and pGF mice at day 0, 2, and 7 of DSS treatment. DSS induces the increment of innate immune cells, including macrophages and dendritic cells, as well as proliferative CD8+ T cells, in SPF mice, while the numbers of innate immune cells and proliferative CD8+ T cells decline in DSS-treated pGF mice. Conversely, more prominent activation of T cells, especially CD4+ regulatory T cells (Tregs), was observed in DSS-treated pGF mice. Further analyses revealed that the major histocompatibility complex-class I (MHC-I) -CD8 and MHC-class II (MHC-II) -CD4 interactions promote the expansion of proliferative CD8+ T cells and CD4+ Tregs respectively. Moreover, we demonstrated that guanine deaminase (GDA) promotes inflammation through facilitating microtubule polymerization in macrophages. 7-methylguanine, a GDA inhibitor, mitigates DSS-induced IBD. In summary, our results demonstrate the pro-inflammatory function of gut microbiota during IBD pathogenesis, shed light on the regulatory mechanism of immune responses, and identify potential therapeutic targets for IBD.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316876" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE255517 é€šè¿‡ä½“å†… CRISPR æ¿€æ´»ç­›é€‰è‚¿ç˜¤å¾®ç¯å¢ƒè°ƒèŠ‚å‰‚ï¼Œåˆç†è®¾è®¡å…ç–«åŸºå› æ²»ç–—ç»„åˆ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immuneã€tumor microenvironment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiens ; Mus musculusThis SuperSeries is composed of the SubSeries listed below.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255517" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>GSE317187 ä¸€ç§æ–°å‹å¡å’¯çƒ·æŸ¥å°”é…®è¡ç”Ÿç‰©é€šè¿‡åŒé‡é¶å‘MDM2-p53è½´å’Œé“æ­»äº¡é€šè·¯ï¼Œè¡¨ç°å‡ºååŒæŠ—å®«é¢ˆç™Œæ´»æ€§ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Xinyi DengSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensCervical cancer remains a serious threat to womenâ€™s health, driving the need for effective and low-toxicity therapeutics.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317187" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>GSE317435 ç ”ç©¶å‘ç°ï¼Œè‘¡è„ç³–å’Œè°·æ°¨é…°èƒºä¾èµ–çš„æ­£äº¤ä»£è°¢çŠ¶æ€ç›¸äº’è§£è€¦ï¼Œç‹¬ç«‹ç»´æŒç™Œç»†èƒå­˜æ´»ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€metabolic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Elizabeth Mazzio ; Renee Reams ; Jean-Baptiste Lamango ; Zonnelle Hanley ; Karam SolimanSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensCancer metabolism is often framed as dependence on cooperative glucose-glutamine fuels; however, whether distinct nutrients enforce discrete metabolic states remains unclear. Glucose utilization is often interpreted under Warburg physiology, involving accelerated glycolysis and clockwise TCA rotation to generate reducing equivalents; yet, emerging evidence suggests that glutamine, under certain conditions, can drive anaplerotic pathways independent of glycolysis, involving a counterclockwise TCA linked to massive lipid biosynthesis. Here, we sought to define how glucose and glutamine independently govern adaptive metabolic states, rather than functioning as cooperative co-fuels, in MDA-MB-231 breast cancer cells. Briefly, cells were cultured under four defined nutrient conditionsâ€”full (+Glc,+Gln), deficient (âˆ’Glc,âˆ’Gln), glucose-only, and glutamine-onlyâ€”and applied transcriptomic, metabolomic, and lipidomic analyses to resolve nutrient-enforced transcriptional and metabolic states.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317435" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>GSE317011 Î²-æ¦„é¦™çƒ¯é€šè¿‡æŠ‘åˆ¶FLT1/PI3K/AKTä¿¡å·é€šè·¯å°†è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒé‡ç¼–ç¨‹ä¸ºM1è¡¨å‹ï¼Œä»è€Œå¢å¼ºPD-L1æŠ‘åˆ¶å‰‚åœ¨è‚ºç™Œä¸­çš„ç–—æ•ˆ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jianmin Wang ; Yongxin YuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusImmune checkpoint inhibitors (ICI), epitomized by PD-1/PD-L1 antibodies, have ushered in a new era in lung cancer treatment. However, ICI monotherapy is only applicable to a small subset of patients with high PD-L1 expression, while most patients with low expression require combination therapies. In this study, we found that Î²-elemene promotes M1 polarization of tumor-associated macrophages (TAM) and enhances the efficacy of PD-L1 antibody (aPD-L1) in C57BL/6 mice. RNA sequencing and surface plasmon resonance revealed that Î²-elemene directly binds to FLT1 and inhibits the PI3K/AKT/FOXO1 signaling pathway, thereby mediating TAM M1 polarization. Using FLT1 knockout mice, we further validated the critical role of FLT1 in TAM polarization and confirmed that M1 polarization synergizes with aPD-L1 treatment. Furthermore, co-immunoprecipitation demonstrated that the intracellular domain of FLT1 interacts with and phosphorylates the p85Î± subunit, initiating downstream signaling cascades. These findings elucidate the synergistic mechanism between Î²-elemene and aPD-L1. Importantly, as both agents are already clinically approved, we plan to conduct a clinical trial to evaluate the efficacy and safety of this combination therapy.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317011" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>GSE316872 ScRNA-seq è¡€æ¶²è½¬å½•ç»„å­¦æ•°æ®é›†æ­ç¤ºäº†æ¢çº½åŸºå› åœ¨ NTM-PD æ‚£è€…ä¸­çš„ä»·å€¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscRNAã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Guoling Yang ; Li Wang ; Xubin Zheng ; Lan Yao ; Jianxia Chen ; Peng Wang ; Wei ShaSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensTo identify and validate peripheral blood mRNA signatures as non-invasive diagnostic biomarkers for nontuberculous mycobacterial pulmonary disease (NTM-PD), we performed an integrated transcriptomic analysis combining scRNA-seq and bulk RNA sequencing (RNA-seq), followed by experimental validation.Peripheral blood samples were collected from a total of 8 participants, including 3 patients with Mycobacterium avium complex pulmonary disease (MAC-PD), 3 patients with Mycobacterium abscessus pulmonary disease (MAB-PD), and 2 healthy controls (HC). All samples were subjected to scRNA-seq to dissect the single-cell transcriptomic landscape of peripheral blood, and paired bulk RNA-seq was conducted simultaneously to achieve comprehensive transcriptomic profiling.Integrated analysis of scRNA-seq and bulk RNA-seq datasets revealed that eight core genes were significantly upregulated in NTM-PD patients compared with HCs. Notably, this gene signature exhibited superior specificity relative to other candidate gene combinations, highlighting its potential as a diagnostic biomarker for NTM-PD.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316872" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE307840 ç»„å­¦è¾…åŠ©è®¾è®¡åŸºå› ç»„ç¼–è¾‘ç­–ç•¥ç”¨äºå…·æœ‰æŒ‘æˆ˜æ€§çš„æ°¸ç”ŸåŒ–ç»†èƒæ¨¡å‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgenome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Patricia Mendoza-Garcia ; Benjamin Keith ; Xiang ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensCRISPR-Cas9 has become a popular genome editing tool for biomedical research and drug development due to its capability to enable precise correction or integration of genetic mutations in the genome. However, precise genome editing competency varies dramatically between cell types depending on their capabilities for DNA damage. In this proof-of-concept study, we took the example of HepG2 and MCF7 to show that omics profiling identifies bottlenecks that are associated with poor precise knock-in (KI) efficiency in hard-to-engineer cells. These bottlenecks include previously described factors such as the predominance of non-homologous end joining (NHEJ) repair and impaired homologous recombination (HR) capability, but also reveals apoptotic priming status of the cells as a limiting factor. Upon further comparative analysis between HepG2 and MCF7 cells, we pinpointed and validated the proliferating cell nuclear antigen (PCNA) as a target to overexpress to enhance precise KI efficiency in MCF7. Overall, we describe how employing a multi-omics approach to characterize cell models of interest can facilitate an in-depth understanding of their editability molecular signature, empowering us to manipulate the activity of key pathways for precise editing, and therefore increase efficiency of desired editing outcomes.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307840" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE291732 èƒ°è…ºç™ŒåŸä½æ¨¡å‹ä¸­Î²-cateninä¾èµ–æ€§å’Œéä¾èµ–æ€§åŸºå› çš„é‰´å®š</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Nathan Harmston ; David Virshup ; Babita MadanSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensWnt signaling regulates metazoan development and homeostasis, in part by Î²-catenin dependent activation and repression of a large number of genes. However, Wnt signaling also regulates genes independent of Î²-catenin, genes that are less well characterized. In this study, using a pan-Wnt inhibitor we performed a comprehensive transcriptome analysis in a Wnt-addicted orthotopic cancer model to delineate the Î²-catenin-dependent and independent arms of Wnt signaling. We find that while a large percentage of Wnt-regulated genes are regulated by Î²-catenin, ten percent of these genes are regulated independent of Î²-catenin. Interestingly, a large proportion of these Î²-catenin independent genes are Wnt-repressed.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291732" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE290575 G549 EP300_KO RNA-seq</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Fatemeh Molaei ; Graham MacLeod ; Stephane AngersSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensEP300 was identified as potential regulator of Injury-response/Mesenchymal state in Glioblastoma stem cells. Our objective was to identify the effect of EP300 KO on transcriptomic signature of Injury-response/Mesenchymal GSC.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290575" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE273354 åˆ©ç”¨ ATAC-seq æ£€æµ‹æ–¹æ³•ç ”ç©¶ VHL å¯¹ Caki-1 ç»†èƒæŸ“è‰²è´¨å¯åŠæ€§çš„æ½œåœ¨å½±å“ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šATAC-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Kenan Zhang ; Lin HeSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensTo investigate the potential impact of VHL on chromatin accessibility, the assay for transposase-accessible chromatin with high throughput sequencing (ATAC-seq) was performed in renal cell carcinoma cells.The VHL wild-type Caki-1 cells were used to generate control or VHL knockout cells by CRISPR/Cas9-mediated genome editing (sgCTR and sgVHL Caki-1 cells).Following ATAC-seq, DNAs were amplified using non-biased conditions, labeled, and sequenced with Illumina NovaSeq 6000.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273354" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 8 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (4æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>åŒ–ç–—ä¼šé‡å¡‘è‚ é“èŒç¾¤ä»¥é˜»æ­¢è½¬ç§»ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šbacteriaã€regex:bacter(ia|ial|ium)ã€gutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šChemotherapyâ€™s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it alters gut bacteria and increases levels of a microbial molecule that travels to the bone marrow. This signal reshapes immune cell production, strengthening anti-cancer defenses and making metastatic sites harder for tumors to colonize. Patient data suggest this immune rewiring is linked to better survival.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/01/260123225920.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>GENCODE CLSé¡¹ç›®â€”â€”é€šè¿‡æ•è·é•¿è¯»é•¿RNAæµ‹åºå¤§è§„æ¨¡æ‰©å±•lncRNAç›®å½•</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencing<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šAn expanded GENCODE lncRNA catalog built using long-read RNA sequencing reveals thousands of new human and mouse genes, improving genome interpretation and disease...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/the-gencode-cls-project-massively-expanding-the-lncrna-catalog-through-capture-long-read-rna-sequencing/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>è¿™ä¸€ä¸ªåŸºå› æˆ–è®¸å¯ä»¥è§£é‡Šå¤§å¤šæ•°é˜¿å°”èŒ¨æµ·é»˜ç—…ç—…ä¾‹ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šAlzheimer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šAlzheimerâ€™s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers found that up to nine in ten cases could be linked to the APOE gene â€” even including a common version once considered neutral. The discovery reshapes how scientists think about risk and prevention. It also highlights a major opportunity for new treatments aimed at a single biological pathway.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/01/260122073623.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>æ–°å‹å‚¬åŒ–å‰‚ä½¿å¡‘æ–™å‡çº§å›æ”¶æ•ˆç‡æ¯”é“‚é‡‘å‚¬åŒ–å‰‚é«˜10å€ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼š10x<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šScientists are finding new ways to replace expensive, scarce platinum catalysts with something far more abundant: tungsten carbide. By carefully controlling how tungsten carbideâ€™s atoms are arranged at extremely high temperatures, researchers discovered a specific form that can rival platinum in key chemical reactions, including turning carbon dioxide into useful fuels and chemicals. Even more promising, the same material proved dramatically better at breaking down plastic waste, outperforming platinum by more than tenfold.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/01/260124003806.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>cancer</td>
<td>4</td>
</tr>
<tr>
<td>immune</td>
<td>4</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>3</td>
</tr>
<tr>
<td>sequencing</td>
<td>2</td>
</tr>
<tr>
<td>tumor</td>
<td>2</td>
</tr>
<tr>
<td>single-cell</td>
<td>2</td>
</tr>
<tr>
<td>gut</td>
<td>2</td>
</tr>
<tr>
<td>regex:gut(-?microbiome)?</td>
<td>2</td>
</tr>
<tr>
<td>genome</td>
<td>1</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>1</td>
</tr>
<tr>
<td>Alzheimer</td>
<td>1</td>
</tr>
<tr>
<td>pathway</td>
<td>1</td>
</tr>
<tr>
<td>tumor microenvironment</td>
<td>1</td>
</tr>
<tr>
<td>metabolic</td>
<td>1</td>
</tr>
<tr>
<td>metabolism</td>
<td>1</td>
</tr>
<tr>
<td>scRNA</td>
<td>1</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>1</td>
</tr>
<tr>
<td>glioma</td>
<td>1</td>
</tr>
<tr>
<td>transcriptome</td>
<td>1</td>
</tr>
<tr>
<td>10x</td>
<td>1</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (8æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314870" target="_blank" rel="noopener noreferrer">GSE314870 HIV æŸå®³å¹¶åˆ©ç”¨è‚ºéƒ¨ Th17 å’Œ Th22 ç»†èƒä»‹å¯¼çš„é’ˆå¯¹ç»“æ ¸åˆ†ææ†èŒçš„å…ç–«ååº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312319" target="_blank" rel="noopener noreferrer">GSE312319 æ‹‰æ–¯ç©†æ£®è„‘ç‚å—ç´¯è„‘ç»„ç»‡çš„å…ç–«å›¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317317" target="_blank" rel="noopener noreferrer">GSE317317 å†…æºæ€§é€†è½¬å½•ç—…æ¯’åˆæˆå¼‚æºåµŒåˆRNAä»¥å¢å¼ºäººç±»æ—©æœŸèƒšèƒå‘è‚²[æ–°ç”ŸRNAæµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317191" target="_blank" rel="noopener noreferrer">GSE317191 å¦Šå¨ æœŸç³–å°¿ç—…ï¼ˆGDMï¼‰ä¸­çš„èƒç›˜é‡å¡‘æ‰°ä¹±è„‚è´¨ä»£è°¢</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317176" target="_blank" rel="noopener noreferrer">GSE317176ï¼šé‡ç”Ÿå‹çŒ´å’ŒTau-P301Lè½¬åŸºå› çŒ´å¤šç§ç»„ç»‡çš„å•æ ¸RNAæµ‹åºæ•°æ®é›†</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299243" target="_blank" rel="noopener noreferrer">GSE299243 äººç±»èƒå„¿å‘è‚²èƒƒä¸å¤šèƒ½å¹²ç»†èƒè¡ç”Ÿèƒƒç±»å™¨å®˜çš„å•ç»†èƒè½¬å½•ç»„æ¯”è¾ƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288070" target="_blank" rel="noopener noreferrer">GSE288070 æ”¾å°„ç–—æ³•è”åˆæ–°è¾…åŠ©å’ŒåŒæ­¥IL-13RÎ±2é¶å‘å…ç–«æ¯’ç´ ç–—æ³•æ²»ç–—å¼¥æ¼«æ€§å†…ç”Ÿæ€§è„‘æ¡¥èƒ¶è´¨ç˜¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264095" target="_blank" rel="noopener noreferrer">GSE264095 osfkbp20-1bçªå˜ä½“ä¸é‡ç”Ÿå‹(ZH11)æ°´ç¨»åœ¨PEGå¤„ç†ä¸‹å¯å˜å‰ªæ¥çš„è½¬å½•ç»„åˆ†æ</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-01-24 21:36</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>